Advanced search
Publication Cover
Libyan Journal of Medicine Volume 9, 2014 - Issue 1
Submit an article Journal homepage
1,378
Views
6
CrossRef citations to date
0
Altmetric
Short Communications

Prevalence of hemoglobin variants in a diabetic population at high risk of hemoglobinopathies and optimization of HbA1c monitoring by incorporating HPLC in the laboratory workup

Kahena BouzidLaboratory of Clinical BiochemistryCharles Nicolle Hospital, Tunis, Tunisia;Faculty of Medicine University El Manar-TunisEl Manar, Tunisia;Laboratory of Engineering of Proteins and Bioactive Molecules: LR 11EES24:LIP-MBTunis, TunisiaCorrespondence[email protected]
,
Habib B. AhmedDepartment of CardiologyCharles Nicolle Hospital, Tunis, Tunisia
,
Eya KalaiLaboratory of Clinical BiochemistryCharles Nicolle Hospital, Tunis, Tunisia
,
Salma BlibecheLaboratory of Clinical BiochemistryCharles Nicolle Hospital, Tunis, Tunisia
,
Nathalie CouqueDepartment of Molecular Genetics and BiochemistryRobert Debré Hospital, Paris, France
,
Karima KhiariDepartment of EndocrinologyCharles Nicolle Hospital, Tunis, Tunisia
,
Afef BahlousLaboratory of Clinical BiochemistryCharles Nicolle Hospital, Tunis, Tunisia
&
Jaouida AbdelmoulaLaboratory of Clinical BiochemistryCharles Nicolle Hospital, Tunis, Tunisia
 show all
Article: 25768 | Received 20 Aug 2014, Accepted 06 Oct 2014, Published online: 27 Oct 2014

References

  • Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27: 1047–53.
  • Bos M, Agyemang C. Prevalence and complications of diabetes mellitus in Northern Africa, a systematic review. BMC Public Health. 2013; 13: 387.
  • Bouguerra R, Alberti H, Salem LB, Rayana CB, Atti JE, Gaigi S, etal. The global diabetes pandemic: the Tunisian experience. Eur J Clin Nutr. 2007; 61: 160–5.
  • American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care. 2011; 34: 11–61.
  • Lin CN, Emery TJ, Little RR, Hanson SE, Rohlfing CL, Jaisson S, etal. Effects of haemoglobin C,D,E, and S traits on measurements of HbA1c by six methods. Clin Chim Acta. 2012; 413: 819–21.
  • Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, etal. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care. 2011; 34: e61–99.
  • Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, etal. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care. 2007; 30: 2453–7.
  • Kleinert PK, Schmidt K, Speer O, Schmugge M, Roschitzki B, Durka SS, etal. Mass spectrometry: a tool for enhanced detection of haemoglobin variants. Clin Chem. 2008; 54: 69–76.
  • Fattoum S. Evolution of hemoglobinopathy prevention in Africa: results, problems and prospect. Mediterr J Hematol Infect Dis. 2009; 1: 2009005.
  • Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008; 86: 480–7.
  • Fattoum S. Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data. Tunis Med. 2006; 84: 687–96.
  • Clarke GM, Higgins TN. Investigation of hemoglobinopathies and thalassemias; review and update. Clin Chem. 2000; 46: 1284–90.
  • Saw S, Loh TP, Yin C, Sethi SK. Identification of hemoglobin variants in samples received for glycated hemoglobin testing. Clin Chim Acta. 2013; 415: 173–5.
  • Behan KJ, Storey NM, Lee HK. Reporting variant hemoglobins discovered during hemoglobin A1c analysis-common practices in clinical laboratories. Clin Chim Acta. 2009; 406: 124–8.
  • Bouzid K, Bahlous A, Ferjani W, Kalai E, Ducrocq R, Ben Mami F, etal. Advantage of HbA1c assay by HPLC D-10 versus cobas integra 400 in a population carrier for HbS and HbC. Clin Lab. 2012; 58: 821–8.
  • Ryan K, Bain BJ, Worthington D, James J, Plews D, Mason A, etal. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol. 2010; 149: 35–49.
  • The DCCT Research Group. Feasibility of centralized measurements of glycated hemoglobin in the diabetes control and complications trial: a multicenter study. Clin Chem. 1987; 33: 2267–71.
  • Haj Khelil A, Denden S, Leban N, Daimi H, Lakhdhar R, Lefranc G, etal. Hemoglobinopathies in North Africa: a review. Hemoglobin. 2010; 34: 1–23.
  • Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem. 2001; 47: 153–63.
  • Jaisson S, Desmons A, Renard B, Chevelle B, Leroy N, Gillery P. Analytical performances of a new enzymatic assay for hemoglobin A1c. Clin Chim Acta. 2014; 434: 48–52.
  • Schnedl WJ, Krause R, Halwachs-Baumann G, Trinker M, Lipp RW, Krejs GJ. Evaluation of HbA1c determination methods in patients with hemoglobinopathies. Diabetes Care. 2000; 23: 339–44.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.